AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Multiple Myeloma Treatments and Clinical Trials
The chapter explores the latest advancements in multiple myeloma treatments, including new drugs like iberdomide, mesigdomide, and teclostomab alongside the potential of combination therapies with daratumumab. It discusses evolving strategies like dual CAR-T targeting, treatment sequencing based on disease biology and patient factors, and the significance of T-cell health in immunotherapies. The chapter also delves into the importance of clinical trials, innovative testing methods, and the potential of blood tests for disease monitoring and MRD testing in myeloma patients.